Hussman Strategic Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,900
Closed -$902K 242
2024
Q1
$902K Sell
18,900
-12,600
-40% -$566K 0.21% 151
2023
Q4
$1.49M Sell
31,500
-7,500
-19% -$312K 0.34% 126
2023
Q3
$1.86M Hold
39,000
0.35% 117
2023
Q2
$2.27M Buy
39,000
+8,000
+26% +$480K 0.42% 87
2023
Q1
$2.22M Buy
+31,000
New +$2.46M 0.35% 117
2021
Q3
Sell
-9,300
Closed -$757K 342
2021
Q2
$757K Sell
9,300
-19,500
-68% -$1.57M 0.16% 221
2021
Q1
$2.17M Buy
28,800
+18,600
+182% +$1.35M 0.45% 75
2020
Q4
$772K Buy
+10,200
New +$664K 0.2% 184

Other funds holding NGVT

Hussman Strategic Advisors's NGVT Position: Q2 2024 in Review

Hussman Strategic Advisors sold out of Ingevity (NGVT) in Q2 2024, closing a stake of 18,900 shares — an estimated $902K sold.

Hussman Strategic Advisors first reported a position in NGVT in Q4 2020 and held it in 8 quarters. The position peaked at $2.27M in Q2 2023. 266 funds tracked by Wall St. Rank hold NGVT as of Q2 2024.

  • Hussman Strategic Advisors reported no remaining Ingevity position as of Q2 2024 after selling out during the quarter.
  • Hussman Strategic Advisors sold 18,900 Ingevity shares in Q2 2024, an estimated $902K.
  • Hussman Strategic Advisors first reported a position in Ingevity in Q4 2020 and held it in 8 quarters.
  • Hussman Strategic Advisors's Ingevity position peaked at $2.27M in Q2 2023.
  • 266 funds tracked by Wall St. Rank held Ingevity as of Q2 2024.

Based on Hussman Strategic Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.